Cytokinetics, Inc. (CYTK)
65.73
+0.31
(+0.47%)
USD |
NASDAQ |
Apr 17, 10:44
Cytokinetics Research and Development Expense (Quarterly) : 101.54M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 2.561B |
| Regeneron Pharmaceuticals, Inc. | 1.481B |
| AtriCure, Inc. | 22.74M |
| Johnson & Johnson | 3.527B |
| Corcept Therapeutics, Inc. | 64.86M |